Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer (Q40038137)

16 September 2017

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer (English)

1 reference

16 September 2017

1 reference

1

1 reference

16 September 2017

Chun-Ling Gao

2

1 reference

16 September 2017

Lakshmi Ravindranath

3

1 reference

16 September 2017

Yongmei Chen

4

1 reference

16 September 2017

Jennifer Cullen

5

1 reference

16 September 2017

David G McLeod

6

1 reference

16 September 2017

Albert Dobi

7

1 reference

16 September 2017

Shiv Srivastava

8

1 reference

16 September 2017

Gyorgy Petrovics

9

1 reference

16 September 2017

Isabell A Sesterhenn

10

1 reference

16 September 2017

7 December 2007

1 reference

16 September 2017

1 reference

16 September 2017

21

1 reference

16 September 2017

2

1 reference

16 September 2017

67-75

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800981

16 September 2017

0 references

cites work

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Biological determinants of cancer progression in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Molecular biology of the Ets family of transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Medicine. Fused genes may help explain the origins of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

ETS-TMPRSS2 fusion gene products in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2:ERG gene fusion: A new genetic marker for prostate cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Evidence of independent origin of multiple tumors from patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

High-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800981

7 January 2021

10.1038/MODPATHOL.3800981

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference